Greenlight Has Record Year As Value Makes A Comeback [David Einhorn’s Full 2022 Investor Letter]

(Urgent) Less than $4 Biotech Announces a Breakthrough in Leukemia Early stage Biotechs can potentially yield significant attention. Those who take interest in these companies are usually the first to notice their products that have the possibility to disrupt big markets. One little Biotech (~ $4) just announced the deployment of a breakthrough in fusion gene map technology for the $15Bn Leukemia treatment market. [Don't Wait: Click here for the company name and ticker symbol!]( [Greenlight Has Record Year As Value Makes A Comeback [David Einhorn’s Full 2022 Investor Letter]]( David Einhorn’s Greenlight Capital had an “exceptionally good year” in 2022. According to a copy of the hedge fund’s letter to investors, which ValueWalk has been able to review, the firm’s partnerships returned 36.6% net of fees and expenses for the year, compared to a loss of 18.1% for the S&P 500 index. […] [Read More]( [UnitedHealth Group Stock: Is This The Bottom?](=) UnitedHealth Group outperformed in Q4. Guidance for 2023 is mixed. Long-term trends are up but near-term action could be sideways until later in 2023. 5 stocks we like better than UnitedHealth Group Shares of UnitedHealth Group (NYSE:UNH) surged in the wake of the Q4 results and 2023 guidance, but the bottom may not be in. […] [Read More](=) [Is Dividend King PPG Industries A Buy Before Earnings?]() PPG Industries reports later this week and may spark a decline in share prices. RPM International foreshadowed these results with a weak outlook of its own. The downturn in housing does not bode well for paint and chemical manufacturers. 5 stocks we like better than PPG Industries Shares of Dividend King PPG Industries (NYSE:PPG) are […] [Read More]() [3 Dividend Stocks For Passive Income]( Dividend stocks are a staple of income investing, but they can benefit almost any stock portfolio. Dividends accounted for 40% of the stock market’s returns since the 1930s, and that figure rose higher during periods of high inflation. Here are some quality companies that pay good dividends to consider adding to your portfolio. 5 stocks […] [Read More]( [Aterian Rises 37% On Strong Sales Guidance Bump; CEO Pledges To Receive 80% Of Salary In Stock](=) Founder and CEO Yaniv Sarig signals confidence in ATER’s outlook with new compensation election for 2023 Shares of technology-enabled consumer products platform provider Aterian Inc (NASDAQ:ATER) closed the trading day with a hefty 37.4% gain after hitting an intra-day high of $1.61(+65.9%) by lunch before day traders banked profits in the afternoon. The spike of […] [Read More](=) [Valuewalk premium advertisement ad unit]() [Privacy Policy]() | [Advertiser Disclosure]() [S&P 500 – More Hopium]( Both S&P 500 and real assets welcomed the BoJ not giving ground, which translates into more money creation in defence of JGB yields, with USD consequences (no relief rally just yet, no). Likewise the incoming data didn‘t send risk assets cratering. Markets want to believe that this disappointments (interpreted in the tweet I linked to), […] [Read More]( [Hedge Fund Outperformance Over The S&P At Largest Point Since 2008]() PivotalPath has released their monthly report, the Pivotal Point Of View, which measures performance among more than 2,500 institutionally-relevant hedge funds, as well as 40+ different hedge fund strategies and $2.5T in total industry assets. Our latest report looks at hedge fund performance in December, as well as 2022 as a whole. Q4 2022 hedge […] [Read More]() [Unsubscribe]( | [Update your profile]( | 347 Fifth Avenue Suite 1402-390 , New York, NY 10016